Newsroom
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death worldwide, yet it remains less recognized than other pulmonary conditions like lung cancer. Dr. Charis Armeftis, a pulmonologist and tuberculosis specialist, emphasizes the lack of data on COPD in Cyprus, which hinders effective prevention and management strategies. He suggests that the General Health System (GeSY) software could help address this gap.
COPD, which includes emphysema and chronic bronchitis, affects millions globally and causes 3.2 million deaths annually. Despite its severity, it remains under the radar compared to lung cancer, even though it is the fourth leading cause of death. Key symptoms include shortness of breath, chronic cough, and increased susceptibility to respiratory infections. As a progressive disease, COPD worsens over time, often leading to severe episodes that require intensive medical care.
While smoking is a primary risk factor, only 20% of smokers develop COPD, suggesting that genetics, occupational hazards, and air pollution also contribute. Early diagnosis is crucial, yet only half of COPD patients are diagnosed early, which delays treatment.
Diagnosis involves spirometry to assess lung function, and treatment aims to alleviate symptoms and improve quality of life. Quitting smoking is essential, and medication like bronchodilators, corticosteroids, antibiotics, and oxygen therapy are used to manage the condition, especially in its advanced stages.
Dr. Armeftis stresses the need for better awareness and data collection to improve the response to COPD in Cyprus and globally.
With information from Ygeia Watch.
